Case Study: a global biopharmaceutical company avoids $250K in costs with SHI International Corp.

A Global Biopharmaceutical Company avoids $250K in AI costs with SHI International Corp.

A global biopharmaceutical company faced significant cost and performance challenges while attempting to scale a critical AI-based image analysis platform for its research. The platform's architecture and a licensing model charged per node, rather than per GPU, meant that scaling would require an investment of over $250,000 in hardware and software that would not meet their long-term needs. They turned to their long-term partner, SHI International Corp., for guidance.

SHI simulated the proposed AI environment in its internal lab, identified the scaling inefficiencies, and advised the customer to pivot to a cloud-based solution instead. This guidance helped the biopharmaceutical company avoid roughly $250,000 in unnecessary hardware and license fees. By implementing SHI's future-ready solution, the customer achieved a more scalable and cost-effective platform for large-scale image analysis, strengthening a trusted partnership built over 15 years.